Last reviewed · How we verify

NCT06295666

Gingival Crevicular Fluid (GCF) Bactericidal Permeability Protein (BPI) and Interleukin (IL)-1 Beta

Completed Last updated 6 March 2024
What this trial tests

trial in Periodontitis in 100 participants. Completed in 20 January 2020.

Timeline
19 February 2019
Primary endpoint
25 November 2019
20 January 2020

Quick facts

Lead sponsorAkdeniz University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date19 February 2019
Primary completion25 November 2019
Estimated completion20 January 2020
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Akdeniz University

Who can join

Eligibility, any sex, with Periodontitis or Gingival Crevicular Fluid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: The aim of this study is to determine the amounts of BPI (Bactericidal permeability protein) and interleukin-1beta (IL-1β) in gingival fluid samples obtained from individuals with periodontally healthy and periodontal disease, to compare these amounts between study groups, and to evaluate their relationship with clinical parameters. In cases where clinical parameters increase, IL-1β amounts also increase significantly. The amount of IL-1β in individuals with periodontal disease is significantly higher compared to healthy individuals. There is positive correlation between BPI and clinical parameters. The amount of BPI in individuals with periodontal disease is significantly higher than in healthy individuals. More studies are needed to better understand the importance and therapeutic effect of BPI in periodontitis

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Akdeniz University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06295666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing